Pregled bibliografske jedinice broj: 1223588
Association between Insertion-Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Treatment Response to Antipsychotic Medications: A Study of Antipsychotic-Naïve First- Episode Psychosis Patients and Nonadherent Chronic Psychosis Patients
Association between Insertion-Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Treatment Response to Antipsychotic Medications: A Study of Antipsychotic-Naïve First- Episode Psychosis Patients and Nonadherent Chronic Psychosis Patients // International Journal of Molecular Sciences, 23 (2022), 20; 1-11 doi:10.3390/ijms232012180 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1223588 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Association between Insertion-Deletion
Polymorphism of the Angiotensin-Converting Enzyme
Gene and Treatment Response to Antipsychotic
Medications: A Study of Antipsychotic-Naïve First-
Episode Psychosis Patients and Nonadherent Chronic
Psychosis Patients
Autori
Nadalin, Sergej ; Dević Pavlić, Sanja ; Peitl, Vjekoslav ; Karlović, Dalibor ; Zatković, Lena ; Ristić, Smiljana ; Buretić-Tomljanović, Alena ; Jakovac, Hrvoje
Izvornik
International Journal of Molecular Sciences (1422-0067) 23
(2022), 20;
1-11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
angiotensin-converting enzyme (ACE) ; antipsychotic medication ; polymorphism ; insertion/deletion ; treatment response
Sažetak
We investigated whether a functional insertion/deletion (I/D) polymorphism of angioten- sin-converting enzyme (ACE) influenced antipsychotic treatment. At baseline, and after 8 weeks of treatment with various antipsychotic medications, we assessed patients’ Positive and Negative Syndrome Scale (PANSS) scores, PANSS factors, and metabolic syndrome-related parameters (fasting plasma lipid and glucose levels, and body mass index). A total of 186 antipsychotic-naïve first-episode psychosis patients or nonadherent chronic psychosis individuals (99 males and 87 females) were genotyped by polymerase chain reaction analysis. The ACE-I/D polymorphism was significantly associated with changes in PANSS psychopathology only (p < 0.05). Compared to ACE- II homozygous males, ACE-DD homozygous and ACE-ID heterozygous males manifested significantly greater decreases in PANSS positive score, PANSS excitement factor, and PANSS cognitive factor. ACE-DD homozygous females manifested higher decreases in PANSS depression factor compared to ACE-II homozygous and ACE-ID heterozygous females. The polymorphism’s effect size was estimated as moderate to strong, while its contribution to the PANSS psycho-pathology ranged from ~5.4–8.7%, with the lowest contribution observed for PANSS positive score changes and the highest for PANSS depressive factor changes. Our results indicated that ACE-I/D polymorphism had a statistically significant but weak gender-specific impact on psychopathology data, and showed no association between ACE-I/D polymorphism and metabolic syndrome-related parameters.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Opća bolnica "Dr. Josip Benčević",
Klinički bolnički centar Rijeka,
Hrvatsko katoličko sveučilište, Zagreb
Profili:
Hrvoje Jakovac
(autor)
Vjekoslav Peitl
(autor)
Smiljana Ristić
(autor)
Alena Buretić-Tomljanović
(autor)
Sanja Dević Pavlić
(autor)
Dalibor Karlović
(autor)
Sergej Nadalin
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE